Case No. IPR2017-01488
`Danford Declaration
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`PFIZER, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________________________________________
`
`Case IPR2017-01488
`U.S. Patent 6,407,213
`____________________________________________
`
`DECLARATION OF ANDREW J. DANFORD IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`Genentech 2038
`Pfizer v. Genentech
`IPR2017-01488
`
`
`Danford Declaration
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`PFIZER, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________________________________________
`
`Case IPR2017-01488
`U.S. Patent 6,407,213
`____________________________________________
`
`DECLARATION OF ANDREW J. DANFORD IN SUPPORT OF
`MOTION FOR ADMISSION PRO HAC VICE
`
`Genentech 2038
`Pfizer v. Genentech
`IPR2017-01488
`
`
`
`
`
`
`I, Andrew J. Danford, declare as follows:
`
`Case No. IPR2017-01488
`Danford Declaration
`
`1.
`
`I was admitted to the Massachusetts Bar in January of 2009 and the New
`
`York Bar in August of 2010 and have been practicing law for over 7 years.
`
`During the entire time that I have been practicing law, my practice has
`
`focused on the field of intellectual property, and particularly, patent
`
`litigation.
`
`2.
`
`I am a member in good standing of the Massachusetts and New York Bars,
`
`and am admitted to practice before the United States District Court for the
`
`District of Massachusetts, the United States Court of Appeals for the First
`
`Circuit, and the United States Court of Appeals for the Federal Circuit.
`
`3. My New York Bar membership number is 4855318. My Massachusetts Bar
`
`membership number is 672342.
`
`4.
`
`Over the course of my career, I have been counsel in numerous patent
`
`litigations. Several of these cases have concerned Patent Office rules and
`
`regulations. For example, I represented Cephalon, Inc. in Apotex Inc. v.
`
`Cephalon, Inc., No. 12-1417 (Fed. Cir.).
`
`5.
`
`I have never been suspended or disbarred from practice before any court or
`
`administrative body.
`
`
`
`
`1
`
`
`
`
`
`
`6.
`
`Case No. IPR2017-01488
`Danford Declaration
`
`I have never had a court or administrative body deny my application for
`
`admission to practice.
`
`7.
`
`I have never had any sanctions or contempt citations imposed on me by any
`
`court or administrative body.
`
`8.
`
`I have read and will comply with Office Patent Trial Practice Guide and the
`
`Board’s Rules of Practice for Trials, as set forth in 37 C.F.R. Part 42.
`
`9.
`
`I agree to be subject to the United States Patent and Trademark Office Rules
`
`of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`10.
`
`I represent Patent Owner Genentech, Inc. in a number of pending IPR
`
`proceedings, including IPR2017-00731 (pro hac vice filed June 8, 2017;
`
`institution denied July 27, 2017, request for rehearing filed August 25,
`
`2017); IPR2017-00737 (pro hac vice granted June 21, 2017; trial instituted
`
`July 27, 2017); IPR2017-00739 (pro hac vice granted June 21, 2017;
`
`institution denied July 27, 2017); IPR2017-00804 (pro hac vice filed June 8,
`
`2017; trial instituted July 27, 2017); IPR2017-00805 (pro hac vice granted
`
`filed June 8, 2017; trial instituted July 27, 2017); IPR2017-01121 (pro hac
`
`vice motion to be filed, pending); IPR2017-01122 (pro hac vice motion to be
`
`filed, pending); IPR2017-01139 (pro hac vice motion to be filed, pending);
`
`IPR2017-01140 (pro hac vice motion to be filed, pending); IPR2017-01373
`
`
`
`
`2
`
`
`
`
`
`
`
`Case No. IPR2017-01488
`Danford Declaration
`
`(pro hac vice motion to be filed, pending); IPR2017-01374 (pro hac vice
`
`motion to be filed, pending); IPR2017-01489 (pro hac vice motion to be
`
`filed, pending); IPR2017-01726 (pro hac vice motion to be filed, pending);
`
`IPR2017-01727 (pro hac vice motion to be filed, pending); IPR2017-01958
`
`(pro hac vice motion to be filed, pending); IPR2017-01959 (pro hac vice
`
`motion to be filed, pending); IPR2017-01960 (pro hac vice motion to be
`
`filed, pending). I have also assisted Patent Owner Genentech, Inc. in a
`
`number of IPR proceedings, including IPR2015-01624, which was
`
`terminated due to settlement; IPR2016-00710, which was terminated due to
`
`settlement; IPR2016-01373, which was not instituted; IPR2016-00460,
`
`which was joined with IPR2015-01624 (which was terminated due to
`
`settlement); IPR2016-00383, which was not instituted; and IPR2017-00047,
`
`which was joined with IPR2016-00710 (which was terminated due to
`
`settlement). I also assisted Patent Owner Genentech, Inc. in IPR2016-01693
`
`(challenging U.S. Patent No. 6,407,213, that patent at issue in this case) and
`
`IPR2016-01694 (challenging U.S. Patent No. 6,407,213, that patent at issue
`
`in this case), which were terminated due to settlement.
`
`11.
`
`I am intimately familiar with the subject matter of U.S. Patent No. 6,407,213
`
`and the prior art at issue in this proceeding. I am also intimately familiar
`
`with antibody technology as a result of my participation in prior antibody-
`
`
`
`
`3
`
`
`
`
`
`
`
`Case No. IPR2017-01488
`Danford Declaration
`
`related patent cases such as IPR2015-01624. I have also assisted Genentech
`
`in prior challenges (IPR2016-01693 and IPR2016-01694) to U.S. Patent No.
`
`6,407,213, the patent at issue in this case. In addition, I have represented life
`
`sciences and pharmaceutical companies, including AbbVie, Bristol-Myers
`
`Squibb, Takeda Pharmaceuticals, AstraZeneca, and Cephalon in patent
`
`litigation matters before federal district courts and the Federal Circuit. The
`
`technology involved in these disputes includes drugs for a variety of disease
`
`conditions, including hyperlipidemia, HIV, hepatitis B, pulmonary diseases,
`
`and sleep disorders.
`
`12.
`
`I hereby declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to
`
`be true; and further that these statements are made with the knowledge that
`
`willful false statements and the like are punishable by fine, imprisonment, or
`
`both, under Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`
`
`
`Dated: September 20, 2017
`
`Case No. IPR2017-01488
`Danford Declaration
`
`
`
`
`Respectfully submitted,
`
`/Andrew J. Danford/
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, Massachusetts 02109
`andrew.danford@wilmerhale.com
`Tel.: 617-526-6806
`Fax: 617-526-5000
`
`
`
`
`5
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
